TICKER INTELLIGENCE
NYSE/NASDAQ: BSX
1
Active Bills
0
Gov't Contracts
50
Congressional Trades
Boston Scientific is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning Boston Scientific, including 1 bill. The legislative sentiment is currently mixed, with both supportive and challenging policy signals in play.
⚠ Rep. Cisneros bought $1K-$15K in CRWD on May 15, 2026 — 5 days before HR8880 (a bill boosting cybersecurity for small businesses) was introduced.
⚠ Gilbert Cisneros bought $100,001 - $250,000 in TSM on 2026-02-09, one day before S2722, the "Taiwan Energy Security and Anti-Embargo Act of 2026," advanced to the Senate Legislative Calendar, a bullish signal for the company.
⚠ Representative Kevin Hern sold $100K-$250K in MCD on 2025-10-23 — 48 days before the LET’S Protect Workers Act (HR6597) was introduced, which proposes increased penalties for labor violations.
⚠ Rep. McCaul bought $1M-$5M in AAPL and NVDA on Jan 30, 2025 — just 7 days before he introduced HR1062, which would lock in permanent tax breaks for US tech corporations like Apple and Nvidia.
The HEAR Act of 2025 is an early-stage, unfunded bill with no Senate companion, no committee hearing, and no markup. It proposes Medicare coverage for hearing aids, which would expand the total addressable market for hearing health, but no publicly traded pure-play hearing aid companies are represented in the provided ticker list. The bill has zero legislative momentum and zero appropriated funding, making it a non-event for current market pricing.
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →